3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1
1
Status
Unknown
1
Terminated
1
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
CNS
3
Conditions
Brain Neoplasms
3
Gynecologic Cancer
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Radiosurgery
114
Temozolomide
104
Bevacizumab
71
Radiotherapy
67
Magnetic Resonance Spectroscopy
67
Carboplatin
29
pembrolizumab
28
Irinotecan
26
Surgical Procedures, Operative
25
Radiation
23
Nivolumab
23
Etoposide
22
Magnetic Resonance Imaging
21
Ipilimumab
21
Erlotinib Hydrochloride
21
Cyclophosphamide
21
Surveys and Questionnaires
19
Aminolevulinic Acid
18
Specimen Handling
16
Pemetrexed
16
Mental Status and Dementia Tests
16
Cisplatin
16
Carmustine
15
Topotecan
14
Trastuzumab
13
Saline Solution
12
Neuropsychological Tests
12
Gefitinib
11
Filgrastim
11
Drug Therapy
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Brain Neoplasms
×
AGuIX
×
Clear all
NCT03818386
2024-06-14
NANORAD2
University Hospital, Grenoble
Phase 2
Unknown
100 enrolled
NCT04094077
2021-06-08
NANOSTEREO
Centre Leon Berard
Phase 2
Terminated
1 enrolled
NCT02820454
2019-06-07
NANO-RAD
University Hospital, Grenoble
Phase 1
Completed
15 enrolled